相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial
Olayemi Osiyemi et al.
CLINICAL INFECTIOUS DISEASES (2022)
Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice
Laura Labarthe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors
Chu-tong Tian et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol
Wanshan Feng et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Franco Maggiolo et al.
BMC INFECTIOUS DISEASES (2022)
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology
Jane Musumali et al.
JOURNAL OF NEUROVIROLOGY (2022)
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
Paul E. Sax et al.
CLINICAL INFECTIOUS DISEASES (2021)
Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach
Chaolong Qin et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistat
Given Lee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Pharmacology of HIV Cure: Site of Action
Aaron S. Devanathan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
Jana Blazkova et al.
NATURE MEDICINE (2021)
Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice
Ruby Kochappan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives
Yanping Huang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes
Yenju Chu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials
Pedro Cahn et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy
Summer Siddiqui et al.
VIRUSES-BASEL (2019)
Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
Corbin G. Thompson et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1:100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies
Michael Aboud et al.
LANCET HIV (2019)
Clinical trials of antiretroviral treatment interruption in HIV-infected individuals
Jillian S. Y. Lau et al.
AIDS (2019)
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
Jong Bong Lee et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
Donn J. Colby et al.
NATURE MEDICINE (2018)
Creation of a long-acting nanoformulated dolutegravir
Brady Sillman et al.
NATURE COMMUNICATIONS (2018)
Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations
Linda C. Alskar et al.
MOLECULAR PHARMACEUTICS (2018)
Systematic De-escalation of Successful Triple Antiretroviral Therapy to Dual Therapy with Dolutegravir plus Emtricitabine or Lamivudine in Swiss HIV-positive Persons
Natascha D. Diaco et al.
ECLINICALMEDICINE (2018)
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Joel Gallant et al.
LANCET (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
Atheer Zgair et al.
SCIENTIFIC REPORTS (2017)
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Franco Maggiolo et al.
BMC INFECTIOUS DISEASES (2017)
Enabling Oral SN38-Based Chemotherapy with a Combined Lipophilic Prodrug and Self-Microemulsifying Drug Delivery System
Vaskor Bala et al.
MOLECULAR PHARMACEUTICS (2016)
Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis
Paloma Benito-Gallo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: In vitro, rat in situ and human in vivo studies
Jef Stappaerts et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
HIV infection
Steven G. Deeks et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys
Lee Moss et al.
XENOBIOTICA (2015)
Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection
R. Chris Rathbun et al.
ANNALS OF PHARMACOTHERAPY (2014)
The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol
Suzanne M. Caliph et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
James B. Whitney et al.
NATURE (2014)
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Courtney V. Fletcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence
Jennifer P. Freeling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Oral bioavailability of cinnarizine in dogs: Relation to SNEDDS droplet size, drug solubility and in vitro precipitation
Anne T. Larsen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
Wolfgang Stoehr et al.
PLOS ONE (2013)
Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
W. Kromdijk et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
N. Thomas et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy
Mariko Horiike et al.
VIROLOGY (2012)
Intestinal lymphatic transport for drug delivery
Jaime A. Yanez et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems
Anne T. Larsen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Determination of a peroxisome proliferator-activated receptor γ agonist, 1-(trans-methylimino-N-oxy)-6-(2-morpholinoethoxy-3-phenyl-1H-indene-2-carboxylic acid ethyl ester (KR-62980) in rat plasma by liquid chromatography-tandem mass spectrometry
Min-Sun Kim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS
Thomas W. North et al.
JOURNAL OF VIROLOGY (2010)
The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles
Natalie L. Trevaskis et al.
PHARMACEUTICAL RESEARCH (2010)
The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons
Pavel Gershkovich et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2009)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Lipid-based Formulations for Danazol Containing a Digestible Surfactant, Labrafil M2125CS: In Vivo Bioavailability and Dynamic In Vitro Lipolysis
Anne Larsen et al.
PHARMACEUTICAL RESEARCH (2008)
Effect of a high-fat meal on absorption and disposition of lipophilic compounds: The importance of degree of association with triglyceride-rich lipoproteins
Pavel Gershkovich et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: Dexanabinol and PRS-211,220
Pavel Gershkovich et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
The effect of different lipid based formulations on the oral absorption of lipophilic drugs:: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats
Arik Dahan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs:: Correlation with in vivo data and the relationship to intra-enterocyte processes in rats
Arik Dahan et al.
PHARMACEUTICAL RESEARCH (2006)
Uptake of lipophilic drugs by plasma derived isolated chylomicrons: Linear correlation with intestinal lymphatic bioavailability
P Gershkovich et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Bioavailability of seocalcitol I:: Relating solubility in biorelevant media with oral bioavailability in rats -: Effect of medium and long chain triglycerides
M Grove et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
The digestion of dietary triacylglycerols
HL Mu et al.
PROGRESS IN LIPID RESEARCH (2004)
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs:: Studies with halofantrine
CJH Porter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Discontinuation of potent antiretroviral therapy:: predictive value of and impact on CD4 cell counts and HIV RNA levels
LA Grant et al.
AIDS (2001)
分享论文
